Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Receivables - Other (2016 - 2023)

Fortress Biotech has reported Receivables - Other over the past 10 years, most recently at $100000.0 for Q4 2023.

  • Quarterly results put Receivables - Other at $100000.0 for Q4 2023, down 75.0% from a year ago — trailing twelve months through Dec 2023 was $100000.0 (down 75.0% YoY), and the annual figure for FY2023 was $100000.0, down 75.0%.
  • Receivables - Other for Q4 2023 was $100000.0 at Fortress Biotech, down from $300000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for FBIO hit a ceiling of $1.3 million in Q4 2019 and a floor of $20000.0 in Q1 2022.
  • Median Receivables - Other over the past 5 years was $100000.0 (2019), compared with a mean of $246600.0.
  • Biggest five-year swings in Receivables - Other: surged 2665.96% in 2019 and later plummeted 95.0% in 2022.
  • Fortress Biotech's Receivables - Other stood at $1.3 million in 2019, then crashed by 92.31% to $100000.0 in 2020, then surged by 500.0% to $600000.0 in 2021, then tumbled by 33.33% to $400000.0 in 2022, then crashed by 75.0% to $100000.0 in 2023.
  • The last three reported values for Receivables - Other were $100000.0 (Q4 2023), $300000.0 (Q1 2023), and $400000.0 (Q4 2022) per Business Quant data.